Skye Bioscience, Inc. (SKYE)
Skye Bioscience Market Cap : 24.03M for April 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Merck & Co., Inc. | 300.20B |
| SIGA Technologies, Inc. | 312.37M |
| ACADIA Pharmaceuticals, Inc. | 3.707B |
| Alnylam Pharmaceuticals, Inc. | 42.72B |
| Savara, Inc. | 1.158B |
Market Cap Related Metrics
| PEG Ratio | -0.0054 |
| Price to Book Value | 1.200 |
| Price | 0.72 |
| Earnings Yield | -195.8% |
| PEGY Ratio | -0.0054 |